Publications by authors named "Katherine Alonso"
Importance: Ozenoxacin, a novel topical antibacterial agent with potent bactericidal activity against gram-positive bacteria, has been developed as a cream with 1% active drug for the treatment of impetigo, a highly contagious bacterial skin infection.
Objectives: To evaluate the efficacy, safety, and tolerability of ozenoxacin cream, 1%, after 5-day twice-daily topical treatment in patients with impetigo.
Design, Setting, And Participants: This randomized, double-blind, vehicle-controlled clinical trial included patients 2 months or older with impetigo who were enrolled at centers in 6 countries from June 2, 2014, through May 30, 2015.
Article Synopsis
- * It is a global initiative that aims to generate a large and standardized data set through a coordinated effort on a single day.
- * The commentary discusses the Consortium's goals for studying marine microbial communities and preserving their functional traits sustainably.